XML 67 R50.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Royalty and Commercial Payment Purchase Agreements - Talphera (Details) - USD ($) $ in Thousands |  | 1 Months Ended | 6 Months Ended |
--- | --- | --- | --- | ---
Jan. 12, 2024 | Apr. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | Dec. 31, 2023
Agreements |  |  |  |  |
Payments of consideration under RPAs, AAAs and CPPAs |  |  | $ 37,000 | $ 14,650 |
Receipts under RPAs, AAAs and CPPAs |  |  | 16,741 | $ 2,934 |
Short-term royalty and commercial payment receivables |  |  | 14,257 |  | $ 14,215
Talphera | Commercial Payment Purchase Agreement |  |  |  |  |
Agreements |  |  |  |  |
Threshold amount for royalties and milestones | $ 20,000 |  |  |  |
Payments of consideration under RPAs, AAAs and CPPAs | $ 8,000 |  |  |  |
Receipts under RPAs, AAAs and CPPAs |  |  | 51 |  |
Short-term royalty and commercial payment receivables |  |  | 0 |  |
Amount of allowance for credit losses |  |  | $ 0 |  |
Talphera | Commercial Payment Purchase Agreement | All customers excluding DoD |  |  |  |  |
Agreements |  |  |  |  |
Royalties and milestones entity has the right to receive as a percentage counterparty is entitled to receive (as a percent) | 100.00% |  |  |  |
Royalty percentage entity has the right to fully retain | 15.00% |  |  |  |
Talphera | Commercial Payment Purchase Agreement | DoD |  |  |  |  |
Agreements |  |  |  |  |
Royalties and milestones entity has the right to receive as a percentage counterparty is entitled to receive (as a percent) | 100.00% |  |  |  |
Royalties shared equally with counterparty (as a percent) | 75.00% |  |  |  |
Talphera | Alora Pharmaceuticals | Asset Purchase Agreement and Marketing Agreement |  |  |  |  |
Agreements |  |  |  |  |
Maximum milestone payments entitled to receive |  | $ 116,500 |  |  |
Talphera | Alora Pharmaceuticals | Asset Purchase Agreement and Marketing Agreement | All customers excluding DoD |  |  |  |  |
Agreements |  |  |  |  |
Royalties entity has right to receive (as a percent) | 15.00% | 15.00% |  |  |
Talphera | Alora Pharmaceuticals | Asset Purchase Agreement and Marketing Agreement | DoD |  |  |  |  |
Agreements |  |  |  |  |
Royalties entity has right to receive (as a percent) | 75.00% | 75.00% |  |  |

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 808 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1 + Details
Name: | us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of allowance for credit loss for right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 326 -SubTopic 20 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479837/606-10-45-3 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 326 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 326 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13 + Details
Name: | us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Maximum eligible milestone payments receivable upon achievement of milestones. May include, but not limited to, development, regulatory, commercial, sales-based and clinical milestones. + References No definition available. + Details
Name: | xoma_EligibleMilestonePaymentsReceivableUponAchievementOfMilestones
Namespace Prefix: | xoma_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of cash outflow for consideration under agreements, including Royalty Purchase Agreements (RPAs), Assignment and Assumption Agreements (AAAs), Commercial payment purchase agreement (CPPAs) and other agreements classified as investing activities. Payments may include upfront payments, one-time payments, milestone payments and contingent consideration payments. + References No definition available. + Details
Name: | xoma_PaymentOfConsiderationUnderAgreementsInvestingActivities
Namespace Prefix: | xoma_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of cash inflow under agreements, including Royalty Purchase Agreements (RPAs), Assignment and Assumption Agreements (AAAs), and Commercial Payment Purchase Agreements (CPPAs), classified as investing activities. Receipts may represent commercial payments attributable to net sales. + References No definition available. + Details
Name: | xoma_ReceiptsUnderAgreementsInvestingActivities
Namespace Prefix: | xoma_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Royalty and commercial payment receivables probable and reasonably estimable to be received within one year or the normal operating cycle, if longer. + References No definition available. + Details
Name: | xoma_RightsReceivableCurrent
Namespace Prefix: | xoma_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Threshold amount for royalties and milestones for determining amount entity has the right to receive. + References No definition available. + Details
Name: | xoma_RoyaltyAndMilestonesReceivableThreshold
Namespace Prefix: | xoma_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Royalties entity has the right to receive as a percentage of net sales. + References No definition available. + Details
Name: | xoma_RoyaltyReceivablePercentageOnNetSales
Namespace Prefix: | xoma_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Royalties and milestones entity has the right to receive as a percentage counterparty is entitled to receive, up to specified threshold. + References No definition available. + Details
Name: | xoma_RoyaltyReceivablePercentageOnNetSalesAndPercentageOfMilestones
Namespace Prefix: | xoma_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Royalty percentage entity has the right to fully retain which counterparty is entitled to receive upon reaching specified threshold. + References No definition available. + Details
Name: | xoma_RoyaltyReceivablePercentageOnNetSalesFullyRetained
Namespace Prefix: | xoma_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Royalties entity has the right to receive as a percentage shared with counterparty upon reaching threshold. + References No definition available. + Details
Name: | xoma_RoyaltyReceivablePercentageOnNetSalesSharedWithCounterparty
Namespace Prefix: | xoma_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_CounterpartyNameAxis=xoma_TalpheraMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=xoma_CommercialPaymentPurchaseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=xoma_AllCustomersExcludingU.s.DepartmentOfDefenseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=xoma_U.s.DepartmentOfDefenseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=xoma_TalpheraMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=xoma_AloraPharmaceuticalsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=xoma_AssetPurchaseAgreementAndMarketingAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |